Loading clinical trials...
Loading clinical trials...
A Phase 1b Study of INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors
Conditions
Interventions
Retifanlimab
Epacadostat
+1 more
Locations
9
United States
The Angeles Clinic and Research Institute
Los Angeles, California, United States
Yale New Haven Hospital
New Haven, Connecticut, United States
University of Florida - Shands Cancer Center
Gainesville, Florida, United States
University of Chicago Medical Center
Chicago, Illinois, United States
Rutgers Cancer Institute of Nj
New Brunswick, New Jersey, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Start Date
August 17, 2018
Primary Completion Date
November 21, 2022
Completion Date
November 21, 2022
Last Updated
February 21, 2023
Lead Sponsor
Incyte Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions